Clinical trials
Outcomes clinical trials
Below are recruiting outcomes clinical trials, each written for real people, not researchers. We’re tracking 2,267 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06481644Recruiting
Study of kids in Asian pediatric ICUs
This study looks at children admitted to pediatric intensive care units (ICUs) in Asia to understand their health patterns and outcomes. It may help improve care for future patients.
SingaporeAges Any age - NCT06483295Recruiting
Mobile app support after lung cancer surgery
This study uses a mobile internet platform (WeChat) to check on how patients are doing after lung cancer surgery. It aims to improve your recovery and quality of life by collecting updates on your health.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT06483698Recruiting
Tracking recovery after early lung cancer surgery
This study follows people with stage I lung cancer to see how they do after surgery. It aims to learn what affects recovery and long-term outcomes.
Beijing, Beijing MunicipalityAges 18–85 - NCT06484062RecruitingPhase 1
Testing cirtuvivint alone and with ASTX727 for leukemia and MDS
This trial tests a new drug called cirtuvivint, given alone or with another drug (ASTX727), for people with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) that has come back or not responded to treatment, and for people with high-risk MDS who have not been treated before. The goal is to see if these combinations work better than current options.
New Haven, ConnecticutAges 18 years+ - NCT06485622Recruiting
Comparing treatments for leg artery hardening
This study is testing different treatments for people with hardened arteries in the legs that cause moderate to severe symptoms like pain, difficulty walking, or sores. The goal is to see which treatment works best to improve blood flow and quality of life.
Guangzhou, GuangdongAges 18 years+ - NCT07692256RecruitingPhase 2
Empagliflozin for heart failure in children
This trial tests if empagliflozin, a diabetes medicine that also helps the heart, can improve symptoms in children with heart failure. It may help kids with severe symptoms or high levels of a heart stress marker called BNP.
Cairo, Cairo GovernorateAges 1 month–18 years - NCT07690267Recruiting
Continuous vital sign monitoring in a surgical ward
This trial tests if keeping a close watch on vital signs like heart rate and breathing using wearable sensors can help spot problems earlier in people recovering from stomach or bowel surgery. It aims to make the recovery safer and catch any complications sooner.
Lørenskog, AkershusAges 18 years+ - NCT07203768Recruiting
Study on how essential thrombocythemia evolves into polycythemia vera
This study watches how a blood condition called essential thrombocythemia (ET) changes into another condition called polycythemia vera (PV) in people with a specific JAK2 mutation. It aims to learn more about these changes and what happens to patients over time.
Rochester, MinnesotaAges 18–100 - NCT07593248Recruiting
Real-World Lung Cancer Outcomes With Targeted Drug Therapy in China
This study looks at how well patients with early-stage lung cancer (that has been surgically removed) do when treated with a targeted drug called EGFR-TKI to prevent cancer from coming back. Researchers will track actual patient outcomes in China from 2023 to 2026.
GuangzhouAges 18 years+ - NCT06486818Recruiting
Ablation for premature heartbeats with unknown cause
This trial studies how well a procedure called ablation works for people with a specific type of extra heartbeat that comes from one spot in the heart and has no clear underlying cause. It looks at what predicts success in the short term.
AsyutAges Any age - NCT06491602Recruiting
Lupus nephritis in children at Sohag Hospital
This study looks at children with lupus nephritis (a kidney problem caused by lupus) to understand what factors affect their disease and outcomes. It may help doctors better treat kids with this condition.
SohagAges 1 month–18 years - NCT06491966Recruiting
Comparing immune responses in bacterial vs. COVID-19 sepsis
This study compares how the body's immune system responds to bacterial sepsis vs. viral sepsis (COVID-19) in intensive care unit patients. The goal is to find better ways to treat each type of life-threatening infection.
Chengdu, SichuanAges 18–90 - NCT06493006Recruiting
Encouraging active travel for employees and students
This study looks at ways to help people walk, bike, or use other active travel to get to work or school. It's open to employees and students who live within about 50 km of the university.
Hanover, Lower SaxonyAges 18–75 - NCT06495554Recruiting
Danish vulva cancer recurrence study
This study looks at how vulva cancer returns (recurrence) over time. It aims to improve follow-up care for people who have had this type of cancer.
Aarhus NAges 18 years+ - NCT06498128Recruiting
Pregnancy safety registry for insomnia drug QUVIVIQ
This registry follows pregnant women with insomnia who used or did not use the sleep medication QUVIVIQ. It aims to track pregnancy and baby outcomes to understand safety.
Durham, North CarolinaAges 15–50 - NCT06500975Recruiting
Long-Term Results After Vestibular Implant
This study checks how well a vestibular implant works over many years for people who already got one in earlier research at Johns Hopkins.
Baltimore, MarylandAges 22–90 - NCT06501781Recruiting
PUSH: Helping People with HIV and Substance Use
This study tests if a program that encourages positive activities (behavioral activation) can help people with HIV or on PrEP who also use substances improve their health. It focuses on those receiving long-acting injectable medications for HIV prevention or treatment.
Washington D.C., District of ColumbiaAges 18–88 - NCT06502717Recruiting
Personalized nutrition program for mood and mental health
This trial tests a personalized nutrition program designed to improve mood and mental health. You'll use a smartphone app and receive meal plans based on your unique needs. It's for adults with mild to moderate depression who are ready to change their diet.
Bothell, WashingtonAges 25–75 - NCT06504485Recruiting
Study of bulevirtide for chronic hepatitis B and D
This trial tests a drug called bulevirtide for people with chronic hepatitis B and D (HDV) co-infection. It looks at how the immune system and virus respond to treatment.
MilanAges 18 years+ - NCT06507878Recruiting
Registry for advanced thyroid cancer treatments
This study collects real-world information from patients with advanced thyroid cancer to better understand how standard treatments and specialized procedures work. Your participation will help improve care for others with this type of cancer.
Houston, TexasAges 18 years+ - NCT06511037RecruitingEarly Phase 1
Dye injection to help see cancer during belly surgery
This study tests a special dye, called pafolacianine, that is injected before surgery to help surgeons see hidden cancer spots in the belly during the operation. The goal is to see if using this dye improves how completely the cancer is removed in people with gastrointestinal cancer that has spread to the belly lining.
Orange, CaliforniaAges 18 years+ - NCT06513273Recruiting
New treatments for AML in the real world
This study looks at how well new AML medicines work in everyday medical practice, outside of clinical trials. If you are starting a newer AML drug like gilteritinib, an IDH inhibitor, oral azacytidine, or others, you may be able to join.
San Giovanni RotondoAges 18 years+ - NCT06518499Recruiting
Comparing three surgeries for pilonidal sinus in women
This trial tests three different surgical methods for pilonidal sinus in women to see which one works best. If you have this condition with 3 or fewer openings and have not had surgery before, this study may be a good fit.
Istanbul, OtherAges 18 years+ - NCT06518889Recruiting
Long-term results of nerve surgery for cerebral palsy
This study looks at children and teens with cerebral palsy who had selective dorsal rhizotomy (SDR) surgery to see how they are doing months to years later. It helps doctors understand the long-term benefits and risks.
LondonAges 7–90
Hear when a new Outcomes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for outcomes?
- Yes. Clin2 currently lists 2,267 recruiting outcomes studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a outcomes trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a outcomes trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.